Last updated: April 2026
CARF Opioid Treatment Program Accreditation — Frequently Asked Questions
CARF accreditation is a federal prerequisite for opioid treatment programs that dispense methadone. These questions address the requirements, process, and common challenges OTPs encounter — from initial certification through renewal.
Is CARF accreditation required for opioid treatment programs?
Yes, for programs that dispense methadone. Under 42 CFR Part 8, SAMHSA cannot certify an opioid treatment program (OTP) unless it holds current accreditation from a CSAT-approved accrediting body. CARF is the most widely used SAMHSA-approved accreditor, accrediting approximately 60 percent of all certified OTPs in the United States. The Joint Commission is the other primary SAMHSA-approved option. Programs that dispense only buprenorphine or naltrexone in an office-based setting (OBOT) are not subject to OTP accreditation requirements unless they also dispense methadone.
What is the difference between SAMHSA certification and CARF accreditation?
They are two separate but interdependent requirements. SAMHSA certification is the federal approval that authorizes an OTP to legally dispense methadone — issued by SAMHSA's Center for Substance Abuse Treatment (CSAT). CARF accreditation is a third-party quality review conducted by an independent accreditation body. SAMHSA will not issue or maintain federal certification unless the OTP also holds current CARF (or equivalent) accreditation. You need both, and you pursue them concurrently during initial OTP development.
What does CARF evaluate during an OTP survey?
CARF evaluates OTPs against its dedicated OTP Standards Manual, which maps directly to the federal opioid treatment standards in 42 CFR Part 8 § 8.12. Key domains include governance and leadership, human resources (credentialing, supervision logs), person-served rights (informed consent, grievance processes), health and safety (medication controls, emergency preparedness), quality improvement (trended outcome data driving decisions), and treatment delivery (individualized plans, counseling integration, discharge planning from admission). Surveyors conduct document reviews, staff interviews, and patient interviews — and patient ability to describe the grievance process is a consistent survey focus.
How long does CARF OTP accreditation last?
Up to three years. CARF awards Three-Year Accreditation when an organization demonstrates substantial conformance to its standards. One-Year Accreditation is awarded when core standards are met but specific areas require improvement. Non-accreditation is the third possible outcome. Under 42 CFR Part 8, surveys must be conducted at least every three years to maintain SAMHSA certification.
What are CARF's fees for OTP accreditation?
CARF charges an application fee of $995 and a survey fee of $1,525 per surveyor per day. Published by CARF in the annual fee schedule (carf.org). Verify current fees with CARF directly, as fees are updated annually. Survey duration and surveyor count depend on program size and complexity. IHS consulting fees are scoped per engagement — contact us for a proposal.
How is the CARF OTP survey conducted?
CARF surveys are scheduled in advance — unlike Joint Commission surveys, which include unannounced visits. CARF uses a consultative peer-review methodology: surveyors are professionals with relevant field experience who take a formative approach. The survey includes an opening conference, document review, leadership and staff interviews, patient interviews, a facility tour, and an exit conference with preliminary findings. The final decision and written report follow after CARF's review of the survey team's submission.
What happens after the CARF OTP survey?
CARF issues an accreditation decision and written report identifying Areas for Improvement (AFIs). Accredited organizations must submit a Quality Improvement Plan (QIP) within 90 days addressing each cited area. SAMHSA-certified OTPs must also submit a SAMHSA Implementation Report to CARF within 180 days of the accreditation decision, verifying corrective actions on any deficiencies related to federal OUD treatment standards. Both documents require structured, evidence-based responses — not just acknowledgment of findings.
What are the most common CARF OTP survey deficiencies?
The most frequently cited deficiencies include: outcome data collected but not trended or used to drive improvement; strategic plans disconnected from performance data; personnel file gaps (missing annual reviews, lapsed credential verifications, incomplete supervision logs); grievance processes patients cannot describe when interviewed; emergency plans not practiced through documented drills; and discharge planning initiated too late. Programs that have not updated policies following the 2024 revision to 42 CFR Part 8 are also at risk of policy-practice misalignment.
What changed in the 2024 revision to 42 CFR Part 8?
HHS published a final rule revising 42 CFR Part 8 in February 2024, effective April 2, 2024, with compliance required by October 2, 2024. Key changes include expanded take-home medication eligibility criteria for stable patients, updated counseling flexibility provisions aligning required counseling with individualized patient need, and revised OTP certification procedures. CARF's 2025 OTP Standards Manual incorporates standards aligned with these revisions. Any OTP whose policies pre-date the 2024 rule needs a gap analysis before its next survey.
What is the difference between an OTP and an OBOT?
An Opioid Treatment Program (OTP) is the only setting authorized to dispense methadone for opioid use disorder under the Narcotic Addict Treatment Act of 1974. OTPs require DEA registration, SAMHSA federal certification, and CARF accreditation — all three. An Office-Based Opioid Treatment (OBOT) setting prescribes buprenorphine and is not subject to OTP federal certification or CARF OTP accreditation requirements unless it adds methadone services.
Can a multi-site OTP network hold a single CARF accreditation?
Yes, under certain conditions. CARF accredits individual programs, but organizations with multiple OTP sites operating under a single organizational structure with centralized quality systems can structure accreditation to cover multiple locations. Scope is determined during the application process. Multi-site operators need careful scoping to ensure all sites operating under the SAMHSA-certified OTP are covered — incorrect scoping creates compliance gaps.
Does CARF OTP accreditation satisfy state licensure requirements?
CARF accreditation satisfies the federal SAMHSA certification prerequisite but does not replace state licensure. Most states require separate OTP licensure from the state behavioral health or substance use disorder authority. Some states grant deemed status or reduced inspection frequency for CARF-accredited OTPs. Requirements — including facility standards, staffing ratios, and medication storage requirements — vary by state and must be confirmed separately.
What DEA registration does an OTP need?
OTPs must register with the DEA as a Schedule II practitioner to administer or dispense methadone, in compliance with 21 CFR Chapter II. DEA registration covers controlled substance recordkeeping, physical security standards for medication storage, and reporting requirements. It must be in place before the OTP can legally dispense methadone. In practice, OTP development involves three parallel tracks: DEA registration, SAMHSA certification, and CARF accreditation — all required before operations begin.
How long does CARF OTP accreditation preparation typically take?
For a new OTP, initial accreditation preparation runs concurrently with DEA and SAMHSA certification timelines, which together can take 6 to 18 months depending on processing. For an existing OTP preparing for renewal, a structured readiness assessment typically takes 4 to 8 weeks, followed by a remediation period before scheduling the survey. Timeline depends on existing documentation depth, prior AFIs, and whether policy updates are needed for the 2024 rule revisions.
What is a SAMHSA Implementation Report and when is it due?
A SAMHSA Implementation Report must be submitted to CARF within 180 days of the accreditation decision. It verifies actions taken to address deficiencies related to the federal OUD treatment standards in 42 CFR Part 8. It is separate from the 90-day Quality Improvement Plan, which addresses all CARF-cited Areas for Improvement. Missing either deadline can put SAMHSA certification at risk. IHS helps OTPs build both documents with the specificity and evidence CARF requires.
Why do OTPs choose CARF over the Joint Commission?
Both are SAMHSA-approved and both satisfy the 42 CFR Part 8 requirement. OTPs choose CARF for several reasons: CARF has historically accredited the majority of U.S. OTPs and has deep OTP-specific familiarity; CARF uses scheduled surveys (not unannounced visits); CARF's consultative peer-review methodology is widely viewed as less adversarial than Joint Commission's compliance-focused approach; and CARF accredits individual programs rather than entire organizations, which can be strategically advantageous. The right choice depends on the organization's existing accreditation portfolio and strategic priorities.
How does IHS help OTPs prepare for CARF accreditation?
IHS provides principal-led OTP accreditation consulting directed by Thomas G. Goddard, JD, PhD — former COO and General Counsel of URAC. Our OTP engagements include a standards readiness assessment, policy and procedure review and remediation, evidence portfolio preparation, staff survey preparation coaching, survey logistics coordination, and post-survey quality improvement planning (90-day QIP and SAMHSA Implementation Report). IHS engagements are scoped to each client's size, accreditation history, and complexity. Contact us for a tailored proposal.
Schedule a Free Discovery Session
Ready to discuss your OTP's accreditation status and next steps? We'll identify your highest-priority gaps in a focused discovery conversation.
Schedule a Free Discovery Session
Last Updated: April 2026